PREDILIFE Logo

PREDILIFE

ISIN: FR0010169920 | Ticker: ALPRE | LEI: 9695006IK5NBKHQU9116
Sector: Health CareSub-Industry: Biotechnology
Country: France

About PREDILIFE

Company Description

Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional.

After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments.

At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people.

We accompany companies, healthcare professionals and employees towards the medicine of tomorrow: predictive, personalized and digital. We are working to make predictive medicine accessible to everyone in order to reduce the number of serious diseases.

We believe that predictive medicine will enable effective prevention and thus reduce the risk of serious diseases.

Year founded

2004

Served area

Worldwide

Headcount

19

Headquarters

39 Rue Camille Desmoulins, 94800 Villejuif – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
02.05.24 None Other Sell EUR 204,000.00
26.04.24 None Other Buy EUR 2,635.60
28.02.24 None Other Buy EUR 6,720.00
26.02.24 None Other Buy EUR 2,150.00
22.02.24 None Other Buy EUR 2,250.00
20.02.24 None Other Other EUR 4,800.00
07.02.24 None Other Buy EUR 2,400.00
24.01.24 None Other Other EUR 5,500.00
19.01.24 None Other Buy EUR 5,500.00
05.12.23 None Other Buy EUR 1,140.00

Capital markets information

ISIN

FR0010169920

LEI

9695006IK5NBKHQU9116

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.